Share

February 12, 2019; 92 (7) Editorial

Psychogenic nonepileptic seizures, conversion, and somatic symptom disorders

Selim R. Benbadis
First published January 4, 2019, DOI: https://doi.org/10.1212/WNL.0000000000006838
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
231

Share

Article Information

vol. 92 no. 7 311-312
DOI: 
https://doi.org/10.1212/WNL.0000000000006838
PubMed: 
30610096
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published January 4, 2019.

Article Versions

Copyright & Usage: 
© 2019 American Academy of Neurology

Author Disclosures

    1. Selim R. Benbadis, MD
  1. Selim R. Benbadis, MD
    2. Scientific Advisory Boards:

    1. Advisory Board for Cyberonics/LivaNova, Eisai, Greenwich, Lundbeck, Neuropace, Sunovion.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial Board: Emedicine-Medscape-WebMD, European Neurology, Epileptic Disorders, Epilepsy and Behavior, Expert Review of Neurotherapeutics.

    Patents:

    1. NONE

    Publishing Royalties:

    1. 1. UpToDate. 2. Medscape/WebMD.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Cyberonics/LivaNova, Eisai, Greenwich, Lundbeck, Neuropace, Sunovion.

    Speakers' Bureaus:

    1. Speakers Bureau: Cyberonics/LivaNova, Eisai, Greenwich, Lundbeck, Neuropace, Sunovion.

    Other Activities:

    1. NONE

    Clinical procedures or imaging studies:

    1. The University of South Florida (Tampa General Hospital) Epilepsy Center is a level-4 center, and as such performs all available treatment: medications, neurostimulation, and surgery.

    Research Support, Commercial Entities:

    1. Clinical trials: Cavion, LivaNova, GW, Sunovion, UCB.

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the University of South Florida, Tampa.
  1. Correspondence
    Dr. Benbadis sbenbadi{at}health.usf.edu
View Full Text

Article usage

Article usage: January 2019 to September 2019

AbstractFullPdfSource
Jan 2019502080Highwire
Feb 201954612675Highwire
Mar 20191672525Highwire
Apr 2019108816Highwire
May 20199237Highwire
Jun 20198067Highwire
Jul 20198768Highwire
Aug 201949108Highwire
Sep 20194925Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me